Albert Einstein College of Medicine is one of the nation’s premier institutions for medical education, basic research and clinical investigation. It is home to some 2,000 faculty members, 750 M.D. students, 350 Ph.D. students attending the Sue Golding Graduate Division — including 125 in the combined M.D./Ph.D. program — and 325 postdoctoral investigators training at our Belfer Institute for Advanced Biomedical Studies. More than 7,000 Einstein alumni are among the nation’s foremost clinicians, biomedical scientists and medical educators.
While education is at the heart of the college’s mission, it is biomedical research that drives the college’s growth. Einstein’s 300 research laboratories are its crucibles of creativity. Long a national leader in biomedical research support from the federal government, Einstein faculty last year received more than $150 million in funding from the National Institutes of Health. In addition, the NIH funds major research centers at Einstein in diabetes, cancer, liver disease and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease and initiatives to reduce and eliminate ethnic and racial health disparities.
Looking to the future, the College of Medicine has embarked on a major expansion program that will effectively double the size of its campus. In June 2009, Einstein marked the opening of the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, a 223,000-square-foot biomedical research building that houses 40 new laboratories. These new state-of-the-art facilities are bringing together world-class scientists and the most advanced cutting-edge technology to facilitate the “translation” of discoveries at the molecular level to the actual treatment, cure and prevention of disease.
